Doximity, Inc.

DOCS Healthcare Health Information Services

Doximity, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $644.9 million, up 13.1% from fiscal 2025.

Revenue
+3.57%
EPS
−42.4%
Free cash flow
+1.87%

Quarter to September 2026, against a year earlier

32.10 1.08 −3.25%
Market cap
$5.9B
P/E
44.4×
Fwd P/E
49.7×
Dividend yield
—
F-score
5/9
Altman Z
17.11
Beneish M
−2.93
Dividend safety
n/a

Doximity, Inc. (DOCS) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
10-Q Sep 30, 2026 P1I2: 7 added · 24 modified
P2I1A: no material changes, the filing says
Receivables outpacing revenue
8-K Nov 5, 2026 2.02 Results of operations and financial condition
8-K Aug 27, 2026 5.07 Submission of matters to a vote of security holders
10-Q Jun 30, 2026 P1I2: 5 added · 7 removed · 38 modified
P2I1A: no material changes, the filing says
8-K Aug 6, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Mar 31, 2026 1: 9 added · 4 removed · 31 modified
1A: 15 added · 75 modified
7: 10 added · 6 removed · 28 modified
8-K May 13, 2026 2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits Officer departure
8-K Apr 13, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure
10-Q Dec 31, 2025
8-K Feb 3, 2026 2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
8-K Dec 24, 2025 8.01 Other events
10-Q Sep 30, 2025
8-K Nov 6, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Aug 28, 2025 5.07 Submission of matters to a vote of security holders
10-Q Jun 30, 2025
8-K Aug 7, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Mar 31, 2025
8-K May 15, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Dec 31, 2024
8-K Feb 6, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Nov 7, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Aug 8, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 16, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure
8-K Feb 8, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Nov 9, 2023 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.